Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 250 of 281 entries
View as:
Phase: N/A
Priority: Normal
Start: 12/01/20
End: 08/01/22
Due: 08/01/23
Phase: N/A
Priority: Normal
Start: 02/01/19
End: 01/31/21
Due: 01/31/22
Phase: N/A
Priority: Normal
Start: 09/30/14
End: 12/31/15
Due: 12/31/16
Phase: N/A
Priority: Normal
Start: 09/17/18
End: 06/30/23
Due: 06/30/24
Phase: N/A
Priority: Normal
Start: 04/01/16
End: 05/30/17
Due: 05/30/18
Phase: N/A
Priority: Normal
Start: 01/01/08
End: 12/31/28
Due: 12/31/29
Phase: N/A
Priority: Normal
Start: 02/29/16
End: 03/31/16
Due: 03/31/17
Phase: N/A
Priority: Normal
Start: 04/30/18
End: 02/28/19
Due: 02/28/20
Phase: N/A
Priority: Normal
Start: 04/17/23
End: 04/30/25
Due: 04/30/26
Phase: N/A
Priority: Normal
Start: 01/05/18
End: 05/05/19
Due: 05/05/20
Phase: N/A
Priority: Normal
Start: 01/01/20
End: 06/01/21
Due: 06/01/22
Phase: N/A
Priority: Normal
Start: 11/30/12
End: 11/30/15
Due: 11/30/16
Phase: N/A
Priority: Normal
Start: 12/30/17
End: 12/30/19
Due: 12/30/20
Local, Targeted Therapy With Alpha Emitter [225Ac]Ac-DOTA-SP (TAT) in Glioma (WHO G3-G4) Progression
Phase: N/A
Priority: Normal
Start: 10/09/24
End: 09/30/27
Due: 09/30/28
Phase: N/A
Priority: Normal
Start: 01/31/13
End: 04/30/14
Due: 04/30/15
Phase: N/A
Priority: Normal
Start: 03/15/22
End: 11/30/23
Due: 11/30/24
Phase: N/A
Priority: Normal
Start: 02/28/13
End: 07/31/14
Due: 07/31/15
Phase: N/A
Priority: Normal
Start: 04/30/15
End: 07/31/19
Due: 07/31/20
Phase: N/A
Priority: Normal
Start: 09/27/20
End: 10/01/21
Due: 10/01/22
Phase: N/A
Priority: Normal
Start: 05/12/25
End: 08/31/27
Due: 08/31/28
Phase: N/A
Priority: Normal
Start: 05/21/19
End: 06/30/20
Due: 06/30/21
Phase: N/A
Priority: Normal
Start: 02/29/20
End: 12/31/23
Due: 12/31/24
Phase: N/A
Priority: Normal
Start: 06/01/25
End: 06/01/26
Due: 06/01/27
Phase: N/A
Priority: Normal
Start: 07/03/23
End: 01/01/27
Due: 01/01/28
Phase: N/A
Priority: Normal
Start: 09/20/20
End: 01/31/29
Due: 01/31/30